SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019056-17-000362
Filing Date
2017-04-07
Accepted
2017-04-07 15:48:15
Documents
2
Group Members
ROSALIND ADVISORS, INC.ROSALIND CAPITAL PARTNERS L.P.ROSALIND MASTER FUND L.P.STEVEN SALAMON

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tonix_13ga1.htm SC 13G/A 121131
2 EXHIBIT A ex_a.htm EX-99.A 8151
  Complete submission text file 0001019056-17-000362.txt   131051
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Subject) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86436 | Film No.: 17749486
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8
Business Address 175 BLOOR STREET EAST SUITE 1316, NORTH TOWER TORONTO A6 M4W 3R8 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1130
Type: SC 13G/A